Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure.
作者信息
Gosling O, Martin M, Clarke E, Smith A, Coombes E, Dawes M
出版信息
Heart. 2005 Sep;91(9):1223-4. doi: 10.1136/hrt.2004.049809.
Abstract
摘要
相似文献
1
Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure.在慢性心力衰竭患者中，血管紧张素II而非醛固酮和肾素，与N末端脑钠肽前体浓度升高呈正相关。
Heart. 2005 Sep;91(9):1223-4. doi: 10.1136/hrt.2004.049809.
2
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.新型口服活性肾素抑制剂阿利吉仑在慢性心力衰竭中的神经体液效应。
Eur J Heart Fail. 2007 Nov;9(11):1120-7. doi: 10.1016/j.ejheart.2007.09.002. Epub 2007 Oct 18.
3
Prognostic value of plasma renin activity in heart failure.血浆肾素活性对心力衰竭的预后价值。
Am J Cardiol. 2011 Jul 15;108(2):246-51. doi: 10.1016/j.amjcard.2011.03.034. Epub 2011 May 3.
4
[Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Feb;19(1):29-31.
5
High prevalence of microalbuminuria in chronic heart failure patients.慢性心力衰竭患者中微量白蛋白尿的高患病率。
J Card Fail. 2005 Oct;11(8):602-6. doi: 10.1016/j.cardfail.2005.05.007.
6
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.主动脉瓣狭窄患者和冠心病患者的醛固酮、血管紧张素II及B型利钠肽在冠状窦和升主动脉水平的情况
Am J Cardiol. 2006 Apr 1;97(7):1068-72. doi: 10.1016/j.amjcard.2005.10.048. Epub 2006 Feb 20.
7
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.口服直接肾素抑制剂阿利吉仑对有症状心力衰竭患者的影响。
Circ Heart Fail. 2008 May;1(1):17-24. doi: 10.1161/CIRCHEARTFAILURE.107.740704.
8
Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.心房颤动时血浆醛固酮和利钠肽升高。
Cardiology. 2007;108(1):35-9. doi: 10.1159/000095671. Epub 2006 Sep 12.
9
10
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure.神经激素激活可预测心力衰竭患者对运动的通气反应和功能能力。
Eur J Heart Fail. 2006 Jan;8(1):46-53. doi: 10.1016/j.ejheart.2005.05.007. Epub 2005 Aug 19.
本文引用的文献
1
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.坎地沙坦对正在服用血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM-Added试验
Lancet. 2003 Sep 6;362(9386):767-71. doi: 10.1016/S0140-6736(03)14283-3.
2
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).缬沙坦心力衰竭试验（Val-HeFT）中脑钠肽和去甲肾上腺素随时间的变化以及死亡率和发病率
Circulation. 2003 Mar 11;107(9):1278-83. doi: 10.1161/01.cir.0000054164.99881.00.
3
Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.脑钠肽在人离体心房和心室心肌中的基因表达：血管紧张素II和舒张期纤维长度的影响
Circulation. 2000 Dec 19;102(25):3074-9. doi: 10.1161/01.cir.102.25.3074.
4
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.以血浆氨基末端脑钠肽（N-BNP）浓度为指导的心力衰竭治疗。
Lancet. 2000 Apr 1;355(9210):1126-30. doi: 10.1016/s0140-6736(00)02060-2.
5
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.严重充血性心力衰竭患者中调节心血管功能的激素及其与死亡率的关系。CONSENSUS试验研究组
Circulation. 1990 Nov;82(5):1730-6. doi: 10.1161/01.cir.82.5.1730.
Zotero 插件